Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of YHD001 in Asthma
This study is currently recruiting participants.
Verified August 2012 by Yuhan Corporation
Study NCT01424124   Information provided by Yuhan Corporation

First Received on August 24, 2011.   Last Updated on August 7, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Asthma
More general conditions related to this trial
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases
Interventions listed in this trial
YHD001 dose level 1
YHD001 dose level 2
Singulair
Placebo
Additional drug interventions recognized in this trial
Montelukast
More general drug interventions related to this trial
Anti-Asthmatic Agents
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Leukotriene Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Yuhan Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services